A Phase I/II study of gemcitabine (GEMZAR)/vinorelbine (NAVELBINE)/liposomal doxorubicin (DOXIL) in relapsed/refractory Hodgkin's disease.

Trial Profile

A Phase I/II study of gemcitabine (GEMZAR)/vinorelbine (NAVELBINE)/liposomal doxorubicin (DOXIL) in relapsed/refractory Hodgkin's disease.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 13 Jul 2015

At a glance

  • Drugs Doxorubicin liposomal (Primary) ; Gemcitabine (Primary) ; Vinorelbine (Primary)
  • Indications Hodgkin's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top